Back to today’s briefing

Story perspectives

Trump's Second Term: Drug Prices vs. Innovation Dilemma

3/9/2025

28 5

Summary

Story summary

Donald Trump's potential second term could reshape the pharmaceutical landscape. While he may advocate for lower drug prices and heightened competition, experts warn that such moves might stifle innovation and limit access to cutting-edge treatments. Stakeholders urge a careful approach to ensure policies promote both affordability and growth in the industry.

1 of 1

Story summary

Donald Trump's potential second term could reshape the pharmaceutical landscape. While he may advocate for lower drug prices and heightened competition, experts warn that such moves might stifle innovation and limit access to cutting-edge treatments. Stakeholders urge a careful approach to ensure policies promote both affordability and growth in the industry.